Considerable disturbances of cardiovascular risk factors in women with diabetes and myocardial infarction

Journal of Diabetes and its Complications

Volumn 19, Issue 1, 2005, Pages 26-34

  Dotevall, Annika ^a   Wilhelmsen, Lars ^a   Lappas, Georg ^a   Rosengren, Annika ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Case control study; Diabetes mellitus; Myocardial infarction; Risk factors; Women

Indexed keywords

FIBRINOGEN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART INFARCTION; HUMAN; LIFESTYLE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; SEX HORMONE DETERMINATION; SITTING; SMOKING HABIT;

EID: 11844296772     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2003.10.001     Document Type: Article

References (47)

1. Abbott R.D., Donahue R.P., Kannel W.B., Wilson P.W.F. The impact of diabetes on survival following myocardial infarction in men vs. women. The Framingham study. JAMA. 260:1988;3456-3460
2. Abbud Z.A., Shindler D.M., Wilson A.C., Kostis J.B. Effect of diabetes mellitus on short-and long-term mortality rates of patients with acute myocardial infarction: a state-wide study. American Heart Journal. 130:1995;51-58
3. Adlerberth A., Rosengren A., Wilhelmsen L. Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. Diabetes Care. 21:1998;535-539
4. Andersson D.K., Svärdsudd K., Tibblin G. Prevalence and incidence of diabetes in a Swedish community 1972-1987. Diabetic Medicine. 8:1991;428-434
5. Austin M.A., Hokanson J.E., Edwards K.L. Hypertriglyceridemia as a cardiovascular risk factor. American Journal of Cardiology. 81:1998;7B-12B
6. Barrett-Connor E.L., Cohn B.A., Wingard D.L., Edelstein S.L. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA. 265:1991;627-631
7. Benderly M., Behar S., Reicher-Reiss H., Boyko V., Goldbourt U. for the SPRINT study group Long-term prognosis of women after myocardial infarction. American Journal of Epidemiology. 146:1997;153-160
8. Bruno G., Cavallo-Perin P., Bargero G., Borra M., D'Errico N., Pagano G. Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin dependent diabetes mellitus. Annals of Internal Medicine. 125:1996;653-657
9. Chun B.Y., Dobson A.J., Heller R.F. The impact of diabetes on survival among patients with first myocardial infarction. Diabetes Care. 20:1997;704-708
10. Clauss A. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens. Acta Haematologica (Basel). 17:1957;237
11. el Khawand C., Jamart J., Donckier J., Chatelain B., Lavenne E., Moriau M., Buysschaert M. Hemostasis variables in type 1 diabetic patients without demonstrable vascular complications. Diabetes Care. 16:1993;1137-1145
12. Eliasson M., Lindahl B., Lundberg V., Stegmayr B. No increase in the prevalence of known diabetes between 1986 and 1999 in subjects 25-64 years of age in northern Sweden. Diabetic Medicine. 19:2002;874-880
13. Elmfeldt D., Wilhelmsen L., Tibblin G., Vedin A., Wilhelmsson C., Bengtsson C. Registration for myocardial infarction in the city of Göteborg, Sweden. Journal of Chronic Diseases. 28:1975;173-186
14. Goodman-Gruen D., Barrett-Connor E. A prospective study of sex-hormone binding globulin and fatal cardiovascular disease in Rancho Bernardo men and women. Journal of Clinical Endocrinology and Metabolism. 81:1996;2999-3003
15. Goodman-Gruen D., Barrett-Connor E. Sex hormone-binding globulin and glucose tolerance in postmenopausal women. Diabetes Care. 20:1997;645-649
16. Gu K., Cowie C.C., Harris M.I. Diabetes and decline in heart disease mortality in US adults. JAMA. 281:1999;1291-1297
17. Haffner S.M., Lehto S., Rönnemaa T., Pyörälä K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New England Journal of Medicine. 339:1998;229-234
18. Hanefeld M., Fischer S., Julius U., Schulze J., Schwanebeck U., Schmechel H., Ziegelasch H.J., Linder J. Risk factors for myocardial infarction and death in newly detected NIDDM: the diabetes intervention study, 11 year follow up. Diabetologia. 39:1996;1577-1583
19. Kanaya A.M., Grady D., Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Archives of Internal Medicine. 162:2002;1737-1745
20. Koivisto V.A., Stevens L.K., Mattock M., Ebeling P., Muggeo M., Stephenson J., Idzior-Valus B. Eurodiab Study Group Cardiovascular disease and its risk factors in IDDM in Europe. Diabetes Care. 19:1996;689-697
21. Krolewski A.S., Kosinski E.J., Warram J.H., Leland O.S., Busick E.J., Asmal A.C., Rand L.I., Christlieb A.R., Bradley R.F., Kahn C.R. Magnitude and determinants of coronary artery disease in juvenile-onset insulin dependent diabetes mellitus. American Journal of Cardiology. 59:1987;750-755
22. Laing I., Olukoga A.O., Gordon C., Boulton A.J.M. Serum sex-hormone-binding globulin is related to hepatic and peripheral insulin sensitivity but not to beta-cell function in men and women with type 2 diabetes mellitus. Diabetic Medicine. 15:1998;473-479
23. Lee W.L., Cheung A.M., Cape D., Zinman B. Impact of diabetes on coronary artery disease in women and men. Diabetes Care. 23:2000;962-968
24. Lehto S., Pyörälä K., Miettinen H., Rönnemaa T., Palomäki P., Tuomilehto J., Laakso M. Myocardial infarct size and mortality in patients with non-insulin-dependent diabetes mellitus. Journal of Internal Medicine. 236:1994;291-297
25. Lidfeldt J., Nerbrand C., Samsioe G., Scherstén B., Agardh C.-D. A screening procedure detecting high-yield candidates for OGT. The Women's Health in the Lund area (WHILA) study: a population based study of middle-aged Swedish women. European Journal of Epidemiology. 17:2001;943-951
26. Lindstedt G., Lundberg P.A., Lapidus L., Lundgren H., Bengtsson C., Björntorp P. Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. Diabetes. 40:1991;123-128
27. Löwel H., Koenig W., Engel S., Hörmann A., Keil U. The impact of diabetes on survival after myocardial infarction: can it be modified by drug treatment? Diabetologia. 43:2000;218-226
28. Lundberg V., Stegmayr B., Asplund K., Eliasson M., Huhtasaari F. Diabetes as a risk factor for myocardial infarction: population and gender perspectives. Journal of Internal Medicine. 241:1997;485-492
29. Malmberg K., Yusuf S., Gerstein H.C., Brown J., Zhao F., Hunt D., Piegas L., Calvin J., Keltai M., Budaj A. for the OASIS registry Impact of diabetes on long-term prognosis in patients with unstable angina and non-q-wave myocardial infarction. Circulation. 102:2000;1014-1019
30. McCall M., Elmfeldt D., Vedin A., Wilhelmsson C., Wedel H., Wilhelmsen L. Influence of a myocardial infarction on blood pressure and serum cholesterol. Acta Medica Scandinavica. 206:1979;477-481
31. Miettinen H., Lehto S., Salomaa V., et al. for the FINMONICA Myocardial Infarction Register Study Group Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care. 21:1998;69-75
32. Natali A., Vichi S., Landi P., Severi S., L'Abbate A., Ferrannini E. Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome. Diabetologia. 43:2000;632-641
33. Norhammar A., Tenerz Å., Nilsson G., Hamsten A., Efendic S., Rydén L., Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 359:2002;2140-2144
34. Pajunen P., Taskinen M.R., Nieminen M.S., Syvänne M. Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus. American Journal of Cardiology. 86:2000;1080-1085
35. Pyörälä K., Pedersen T.R., Kjekshus J., Faergeman O., Olsson A.G., Thorgeirsson G. the Scandinavian Simvastatin Survival Study (4S) Group Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroups analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care. 20:1997;614-620
36. Rosengren A., Spetz C.-L., Köster M., Hammar N., Alfredsson L., Rosén M. Sex difference in survival after myocardial infarction in Sweden. Data from the Swedish National Acute Myocardial Infarction register. European Heart Journal. 22:2001;314-322
37. Saltin B., Grimby G. Physiological analysis of middle-aged and old former athletes. Comparisons with still active athletes of the same age. Circulation. 38:1968;1104-1115
38. Schrott H.G., Bittner V., Vittinghoff E., Herrington D.M., Hulley S. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS research group. JAMA. 277:1997;1281-1286
39. Sprecher D.L., Pearce G.L., Park E.M., Pashkow F.J., Hoogwerf B.J. Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients. Diabetes Care. 23:2000;1648-1653
40. Tunstall-Pedoe H. Myth and paradox of coronary risk and the menopause. Lancet. 351:1998;1425-1427
41. Turner R.C., Millns H., Neil H.A.W., Stratton I.M., Manley S.E., Matthews D.R., Holman R.R. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS:23). BMJ. 316:1998;823-828
42. Ulvenstam G., Aberg A., Bergstrand R., Johansson S., Pennert K., Vedin A., Wilhelmsen L., Wilhelmsson C. Long-term prognosis after myocardial infarction in men with diabetes. Diabetes. 43:1985;787-792
43. Uusitupa M.I.J., Niskanen L.K., Siitonen O., Voutilainen E., Pyörälä K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin dependent) diabetic and non-diabetic subjects. Diabetologia. 36:1993;1175-1184
44. Vilbergsson S., Sigurdsson G., Sigvaldason H., Sigfusson N. Coronary heart disease mortality amongst non-insulin-dependent diabetic subjects in Iceland: the independent effect of diabetes. The Reykjavik Study 17-year follow up. Journal of Internal Medicine. 244:1998;309-316
45. WHO MONICA Project Principal Investigators World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): a major international collaboration. Journal of Clinical Epidemiology. 41:1988;105-114
46. Wilhelmsen L., Johansson S., Rosengren A., Wallin I., Dotevall A., Lappas G. Risk factors for cardiovascular disease during the period 1985-1995 in Göteborg, Sweden. The GOT-MONICA project. Journal of Internal Medicine. 242:1997;199-211
47. Wilhelmsen L., Svärdsudd K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. New England Journal of Medicine. 311:1984;501-505